Decentralized Trials STREAM

  1. Transformative Cardiac Solutions 7/30/2025

    While traditional ECGs require on-site visits, delaying data and increasing drop-out risk, AliveCor''s FDA-Cleared ECG devices can be used on-site as well as in decentralized and fully remote trials.

  2. Trials And Tribulations Of Electronic Patient Consent: Removing Barriers To eConsent Adoption 6/3/2021

    After a decade of dabbling with eConsent, how can sponsors and technology providers meet the demand to bring clinical trials directly to the patient at a global scale? In this webinar, you’ll learn strategies to overcome the persistent challenges in eConsent adoption and gain the benefits promised from successful decentralized trials with remote capabilities for patients and sites.

  3. Technology Overload: Addressing Site Challenges Of Digital Trials 5/23/2024

    Watch as speakers explore the experiences of sites conducting digital and hybrid trials, discussing the critical benefits of a change management strategy and a unified digital trial platform.

  4. Digital Physical Activity Measures In Phase 3 Immunology Trials 2/25/2025

    Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.

  5. Leveraging DHTs To Improve Data Collection And Analysis 2/25/2025

    How can wearable DHTs be leveraged to measure physical activity in patients with immunological diseases, enhancing clinical trials and advancing drug development?

  6. Creating The Digital Foundation For Scale In Clinical Development 8/11/2023

    Learn how CROs, pharma, and biotechs are using digital trial methods to scale efficiencies across the entirety of their clinical trial portfolio for maximum ROI.

  7. DCTs: The Site Perspective 5/8/2024

    Putting patients and sites on the same platform coordinates and simplifies eCOA patient data collection and provides a 360 degree view of the patient. See how through Dr. Aaliyah's story.

  8. Are You Realizing ROI Across Your Portfolio Of Studies? 9/20/2022

    Research shows that the global DCT market will reach $14B by 2026. Research also suggests that up to 90% of clinical trials are at risk of failure. Faulty trial designs, patient retention, costs and flawed data collection are drivers for the failure rate in clinical trials. The risks of study failure are reduced by taking a patient- first enterprise platform approach.

  9. A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data 2/25/2025

    Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.

  10. On-site ePRO Solutions For Flexible Data Collection Across Devices 3/17/2026

    Optimize flexible electronic patient-reported outcomes that allow participants to switch between site-owned devices, personal hardware, and remote completion.